Miriplatin
Miriplatin is a drug used to treat hepatocellular carcinoma. It is a lipophilic platinum complex that is used in transcatheter [arterial chemoembolization]. Miriplatin was approved by Japan's Pharmaceuticals and [Medical Devices Agency] in 2009.